These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36502498)

  • 21. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
    Bruckner L; Gigliotti F
    Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.
    Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
    Clin Microbiol Infect; 2004 Oct; 10(10):899-903. PubMed ID: 15373884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City].
    Heine AC; García S; Barberis C; Vay C; E Mollerach M; Bonofiglio L; Famiglietti Á
    Rev Argent Microbiol; 2019; 51(1):26-31. PubMed ID: 29941157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
    Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
    Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species-specific difference in antimicrobial susceptibility among viridans group streptococci.
    Chun S; Huh HJ; Lee NY
    Ann Lab Med; 2015 Mar; 35(2):205-11. PubMed ID: 25729722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the MicroScan MICroSTREP plus antimicrobial panel for testing β-hemolytic streptococci and viridans group streptococci.
    Kim SJ; Uh Y; Jang IH; Lee KS; Park SD; Yoon KJ
    Korean J Lab Med; 2011 Jul; 31(3):185-90. PubMed ID: 21779193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy.
    Sheehy J; Scott AP; Henden AS; Kennedy G; Redmond AM; Stewart AG
    J Antimicrob Chemother; 2024 Aug; 79(8):2040-2047. PubMed ID: 38973602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
    Paulus S; Dobson S; Rassekh S; Blondel-Hill E
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America.
    Diekema DJ; Beach ML; Pfaller MA; Jones RN;
    Clin Microbiol Infect; 2001 Mar; 7(3):152-7. PubMed ID: 11318814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility of viridans group streptococci.
    Tuohy M; Washington JA
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicomicrobiological risk factors for infective endocarditis in viridans group streptococci bacteraemia.
    Bae J; Park JH; Lee M; Jo HJ; Lee CM; Kang CK; Choe PG; Park WB; Kim NJ; Kim I; Oh MD
    J Antimicrob Chemother; 2024 Sep; 79(9):2327-2333. PubMed ID: 38973607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.
    Rosser SJ; Alfa MJ; Hoban S; Kennedy J; Harding GK
    J Clin Microbiol; 1999 Jan; 37(1):26-30. PubMed ID: 9854058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years.
    Peri AM; Edwards F; Henden A; Harris PNA; Chatfield MD; Paterson DL; Laupland KB
    Clin Exp Med; 2023 Dec; 23(8):4563-4573. PubMed ID: 37815735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
    Spanik S; Trupl J; Kunova A; Botek R; Sorkovska D; Grey E; Studena M; Lacka J; Oravcova E; Krchnakova A; Rusnakova V; Svec J; Krupova I; Grausova S; Stopkova K; Koren P; Krcmery V
    Scand J Infect Dis; 1997; 29(3):245-9. PubMed ID: 9255883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases.
    Mogi A; Nishi JI; Yoshinaga M; Harada H; Narahara S; Kawakami K; Maruyama I
    Pediatr Infect Dis J; 1997 Dec; 16(12):1140-4. PubMed ID: 9427459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical impact of patients with bloodstream infection with different groups of Viridans group streptococci by using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
    Su TY; Lee MH; Huang CT; Liu TP; Lu JJ
    Medicine (Baltimore); 2018 Dec; 97(50):e13607. PubMed ID: 30558035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Viridans Group Streptococcal Bacteremia in Neutropenic and Non-neutropenic Patients: A Single Center Case-Case-Control Study.
    Dulanto Chiang A; Sinaii N; Palmore TN
    Open Forum Infect Dis; 2018 Jan; 5(1):ofx260. PubMed ID: 29955617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
    Bilavsky E; Eliahou R; Keller N; Yarden-Bilavsky H; Harel L; Amir J
    J Infect; 2008 Apr; 56(4):244-8. PubMed ID: 18295897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.